Literature DB >> 30879816

Randomized, controlled, superiority study of extended duration of therapy with an intramammary antibiotic for treatment of clinical mastitis.

S McDougall1, L Clausen2, J Hintukainen3, J Hunnam4.   

Abstract

The objectives of this study were to evaluate the efficacy of therapy of clinical mastitis following intramammary infusion of 2 durations of intramammary antibiotic therapy and to analyze clinical and microbiology data at enrollment or within 4 d of commencement of treatment as potential predictors of subsequent clinical and bacteriological cure. A total of 304 glands were randomly assigned to intramammary treatment with a combination of amoxicillin, clavulanic acid, and prednisolone either 3 times at 12-h intervals (3×12, n = 156) or 5 times at 12-h intervals (5×12 hourly, n = 148). At enrollment (d 0), assessments were made of the cow's demeanor, rectal temperature, teat-end hyperkeratosis, presence of heat or swelling of the gland, presence of clots in the milk, and California Mastitis Test (CMT) score. Cows were revisited on d 4, 14, and 21 and assessed for rectal temperature, the presence of clots in milk, heat or swelling of the gland, and CMT score. Milk samples were collected from enrolled glands for bacteriology (d 0, 4, 14, and 21) and for somatic cell count (d 14 and 21). Data were analyzed using generalized linear models. Treatment group was the key independent variable, but herd was included in the models. Other potentially confounding variables were included where associated at the bivariate level. A second series of analyses were undertaken to predict likelihood of clinical and bacteriological cure using the clinical signs cow age and days in milk, as well as bacteriological results at d 0 and 4. Although we found a higher clinical failure rate in the 3×12 than 5×12 hourly treatment group (28.2 ± 5.0 vs. 13.4 ± 3.6%, respectively), we noted no difference in bacteriological cure percentage (73.3 ± 7.8 vs. 72.0 ± 7.4%, respectively). The presence of heat or swelling at d 4, days in milk at initiation of treatment, age of the cow, and change in CMT score between d 0 and 4 were predictive of clinical and bacteriological cure. We concluded that increasing the duration of treatment resulted in significantly fewer clinical failures, but had no effect on cure proportion, somatic cell count, or new infection rate. Knowledge of cow age and days in milk and clinical signs were predictive of clinical and bacteriological cure proportion and may provide guidance for producers, under veterinary direction, as to when to extend or recommence therapy.
Copyright © 2019 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  duration; mastitis; modelling; therapy

Mesh:

Substances:

Year:  2019        PMID: 30879816     DOI: 10.3168/jds.2018-15141

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  7 in total

1.  Characterization of lytic activity of Phage SAvB14 on Staphylococcus aureus variant bovis.

Authors:  Yulia Horiuk; Victor Horiuk; Mykola Kukhtyn; Anatoliy Tsvihun; Sergiy Kernychnyi
Journal:  J Adv Vet Anim Res       Date:  2020-08-22

Review 2.  What Is Success? A Narrative Review of Research Evaluating Outcomes of Antibiotics Used for Treatment of Clinical Mastitis.

Authors:  Pamela L Ruegg
Journal:  Front Vet Sci       Date:  2021-02-02

Review 3.  Advances in therapeutic and managemental approaches of bovine mastitis: a comprehensive review.

Authors:  Khan Sharun; Kuldeep Dhama; Ruchi Tiwari; Mudasir Bashir Gugjoo; Mohd Iqbal Yatoo; Shailesh Kumar Patel; Mamta Pathak; Kumaragurubaran Karthik; Sandip Kumar Khurana; Rahul Singh; Bhavani Puvvala; Rajendra Singh; Karam Pal Singh; Wanpen Chaicumpa
Journal:  Vet Q       Date:  2021-12       Impact factor: 3.320

4.  Therapy of Subclinical Mastitis during Lactation.

Authors:  Scott McDougall; Laura M Clausen; Hassan M Hussein; Chris W R Compton
Journal:  Antibiotics (Basel)       Date:  2022-02-07

5.  Bacteriophage Cocktails Protect Dairy Cows Against Mastitis Caused By Drug Resistant Escherichia coli Infection.

Authors:  Mengting Guo; Ya Gao; Yibing Xue; Yuanping Liu; Xiaoyan Zeng; Yuqiang Cheng; Jingjiao Ma; Hengan Wang; Jianhe Sun; Zhaofei Wang; Yaxian Yan
Journal:  Front Cell Infect Microbiol       Date:  2021-06-17       Impact factor: 5.293

Review 6.  Probiotics and Postbiotics as Substitutes of Antibiotics in Farm Animals: A Review.

Authors:  Daria Zamojska; Adriana Nowak; Ireneusz Nowak; Ewa Macierzyńska-Piotrowska
Journal:  Animals (Basel)       Date:  2021-12-01       Impact factor: 2.752

7.  Antimicrobial Selection for the Treatment of Clinical Mastitis and the Efficacy of Penicillin Treatment Protocols in Large Estonian Dairy Herds.

Authors:  Anri Timonen; Marju Sammul; Suvi Taponen; Tanel Kaart; Kerli Mõtus; Piret Kalmus
Journal:  Antibiotics (Basel)       Date:  2021-12-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.